Bayer Calls Off Search For Pharma Partner; Levitra Adding Value To Business
Executive Summary
Bayer will retain its pharmaceuticals business as a stand-alone company after calling off a 20-month search for a pharma partner, Bayer CEO Werner Wenning said during an analyst call Nov. 7
You may also be interested in...
Bayer Focuses Internally: In-Licensing, In-House R&D Are Priorities
Bayer will focus on seeking licensing deals for its pharmaceutical business after abandoning a search for a more extensive partnership, CEO Werner Wenning told analysts Nov. 11
Bayer Layoffs, Spin-Offs Will Leave “Mid-Sized” European Company
Bayer is comfortable being a mid-sized European pharmaceutical company
Bayer Focuses Internally: In-Licensing, In-House R&D Are Priorities
Bayer will focus on seeking licensing deals for its pharmaceutical business after abandoning a search for a more extensive partnership, CEO Werner Wenning told analysts Nov. 11